Integra Lifesciences Holdings (IART) Payables (2009 - 2026)

Integra Lifesciences Holdings' Payables history runs 18 years deep, the most recent figure standing at $87.9 million for Q1 2026.

• In Q1 2026, Payables fell 3.67% year-over-year to $87.9 million; the TTM figure through Mar 2026 stood at $87.9 million (down 3.67% YoY), while the FY2025 annual figure was $95.7 million, up 16.03% from the prior year.
• Payables came in at $87.9 million for Q1 2026 at Integra Lifesciences Holdings, down from $95.7 million in the prior quarter.
• In the past five years, Payables ranged from a high of $112.8 million in Q1 2023 to a low of $69.5 million in Q2 2022.
• A 5-year average of $91.8 million and a median of $92.3 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables surged 65.11% in 2022 and decreased 16.98% in 2024, its largest moves.
• Integra Lifesciences Holdings' Payables stood at $102.1 million in 2022, then dropped by 9.57% to $92.3 million in 2023, then decreased by 10.64% to $82.5 million in 2024, then climbed by 16.03% to $95.7 million in 2025, then declined by 8.13% to $87.9 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $87.9 million, $95.7 million, and $92.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison